Ftse Mib
38.359,70
1,01%
DAX
22.798,09
1,40%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
95.466,98
-0,69%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Edgewise Therapeutics Inc (EWTX) Edgewise Therapeutics Inc (EWTX) Notizie

Edgewise Therapeutics Inc

EWTX
25,39
-0,63 (-2,42%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202522:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202522:19EDGAR2Form 144 - Report of proposed sale of securities
05/2/202522:09EDGAR2Form 144 - Report of proposed sale of securities
03/2/202522:36EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
24/1/202501:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202501:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202514:20EDGAR2Form 8-K - Current report
22/1/202514:00BWEdgewise Therapeutics Strengthens Leadership Team to Support..
13/1/202514:00BWEdgewise Therapeutics Provides Corporate Update and..
07/1/202514:00BWEdgewise Therapeutics to Present at the 43rd Annual J.P...
31/12/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:10EDGAR2Form 144 - Report of proposed sale of securities
16/12/202423:25EDGAR2Form 8-K - Current report
16/12/202412:00BWEdgewise Therapeutics Announces Positive Topline Results..
05/12/202420:32BWEdgewise Provides Statement Regarding Company’s Relationship..
26/11/202412:00BWEdgewise Therapeutics to Present at the Piper Sandler 36th..
07/11/202414:53EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/11/202414:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:00EDGAR2Form 8-K - Current report
07/11/202414:00BWEdgewise Therapeutics Reports Third Quarter 2024 Financial..
01/10/202414:00BWEdgewise Therapeutics to Present on Sevasemten (EDG-5506)..
25/9/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202422:46EDGAR2Form 144 - Report of proposed sale of securities
20/9/202422:29EDGAR2Form 144 - Report of proposed sale of securities
19/9/202413:00BWEdgewise Therapeutics Announces Positive Top-Line Data from..
17/9/202422:01BWEdgewise Therapeutics to Host Webcast Event to Discuss..
14/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202423:07EDGAR2Form 8-K - Current report
08/8/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:00EDGAR2Form 8-K - Current report
08/8/202414:00BWEdgewise Therapeutics Reports Second Quarter 2024 Financial..
13/6/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:10EDGAR2Form 8-K - Current report
10/5/202415:07EDGAR2Form S-3ASR - Automatic shelf registration statement of..
10/5/202414:00BWEdgewise Therapeutics to Present at the RBC Capital Markets..
09/5/202415:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:00EDGAR2Form 8-K - Current report
09/5/202414:00BWEdgewise Therapeutics Reports First Quarter 2024 Financial..
07/5/202415:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202415:14EDGAR2Form 8-K - Current report
07/5/202414:00BWEdgewise Therapeutics Appoints Arlene Morris to its Board of..
06/5/202414:00BWEdgewise Therapeutics Doses First Patient in Phase 2..
23/4/202414:00BWEdgewise Receives European Medicines Agency (EMA) Orphan..
15/4/202422:05BWEdgewise Therapeutics Announces Positive Two-Year Topline..
28/3/202413:00BWEdgewise Therapeutics Announces Upcoming Podium Presentation..
27/3/202413:00BWEdgewise Therapeutics to Present at the Cantor Virtual..
Apertura: 26,36 Min: 24,92 Max: 26,56
Chiusura: 26,02

La tua Cronologia

NASDAQ
EWTX
Edgewise Therapeutics
BIT
UC9152
Unicredit Bank
TG
DJAD
Lyxor Asset Management L...
TSX
9563
Atlas Technologies
LSE
0RGI
Cosmo Pharmaceuticals Nv
USOTC
PEMSF
Pacific Empire Minerals (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci